Picture of Qiagen NV logo

QGEN Qiagen NV Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

Annual income statement for Qiagen NV, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:20-F20-F20-F20-F20-F
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,5261,8702,2522,1421,965
Cost of Revenue
Gross Profit1,0051,2331,4511,3851,234
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1,5481,4841,6221,6101,560
Operating Profit-21.3386630531406
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-77.8439626513430
Provision for Income Taxes
Net Income After Taxes-41.5359513423341
Net Income Before Extraordinary Items
Net Income-41.5359513423341
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-41.5359513423341
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.7982.072.382.061.67